BERKELEY HEIGHTS, N.J., April 11, 2016 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC), (NASDAQ:CYCCP); ...
-- Successfully Completed Initial Public Offering, Raising $74.9 Million in Gross Proceeds -- Presented ...
Approximately 70% of the planned total of 444 patients have been enrolled in the ...
